International Consolidated Airlines Aktie
WKN DE: A1H6AJ / ISIN: ES0177542018
|
11.11.2022 14:58:00
|
BioNTech and Fosun Pharma Receive Emergency Use Authorization for Omicron-BA.4/BA.5 Adapted Bivalent Vaccine in Hong Kong and Special Import Authorization for Macau
Omicron BA.4/BA.5-adapted bivalent vaccine will become available in Hong Kong SAR and Macau SAR as a booster dose for individuals 12 years of age and older BA.4/BA.5-adapted bivalent vaccine combines 15-µg of mRNA encoding the wild-type spike protein found in the original COVID-19 mRNA vaccine and
Weiter zum vollständigen Artikel bei "RSS Importer"
Weiter zum vollständigen Artikel bei "RSS Importer"
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu International Consolidated Airlines S.A.mehr Nachrichten
Analysen zu International Consolidated Airlines S.A.mehr Analysen
| 22.10.25 | International Consolidated Airlines Buy | Goldman Sachs Group Inc. | |
| 21.10.25 | International Consolidated Airlines Outperform | Bernstein Research | |
| 09.10.25 | International Consolidated Airlines Outperform | Bernstein Research | |
| 07.10.25 | International Consolidated Airlines Outperform | RBC Capital Markets | |
| 02.10.25 | International Consolidated Airlines Overweight | JP Morgan Chase & Co. |
Aktien in diesem Artikel
| BioNTech (ADRs) | 91,20 | 1,73% |
|
| International Consolidated Airlines S.A. | 4,67 | 0,97% |
|
| International Consolidated Airlines Group S.A. (spons. ADRs) | 10,85 | 1,31% |
|